跳至主要内容
临床试验/JPRN-UMIN000035047
JPRN-UMIN000035047已完成未知

Clinical investigation of ninjin'yoeito for psychiatric symptoms and physical frailty among patients with mild cognitive impairment and Alzheimer's disease. - Effect of ninjin'yoeito among patients with mild cognitive impairment and Alzheimer's disease.

ational Center Geriatrics and Gerontology0 个研究点目标入组 10 人开始时间: 2018年11月28日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
65years-old 至 89years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients who have been taken other kampo medicines in the past month. 2) Patients who have MMSE score of 10 points or less. 3) Patients who switched or newly started using anti-dementia medications within 3 months from the start of the survey. 4) Patients who have been taking sweetroot-containing drug and/or glycyrrhizinate-containing drug. 5) Patients who switched or newly started using antipsychotic medications within 3 months from the start of the survey. 6) Patients who have mental disorders caused by cerebrovascular disorders, head injuries, brain tumors, or encephalitis. 7) Patients whom investigators consider to be ineligible.

研究者

发起方
ational Center Geriatrics and Gerontology

相似试验